282 related articles for article (PubMed ID: 31696904)
1. The health threat of drugs of abuse adulteration by new psychoactive substances.
Minutillo A; Palmi I; Mastrobattista L
Clin Ter; 2019; 170(6):e425-e426. PubMed ID: 31696904
[TBL] [Abstract][Full Text] [Related]
2. New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard.
Zaami S
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9681-9690. PubMed ID: 31799633
[TBL] [Abstract][Full Text] [Related]
3. Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances.
Di Trana A; Berardinelli D; Montanari E; Berretta P; Basile G; Huestis MA; Busardò FP
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498947
[TBL] [Abstract][Full Text] [Related]
4. Adulteration Practices of Psychoactive Illicit Drugs: An Updated Review.
Solimini R; Rotolo MC; Pellegrini M; Minutillo A; Pacifici R; Busardò FP; Zaami S
Curr Pharm Biotechnol; 2017; 18(7):524-530. PubMed ID: 28699480
[TBL] [Abstract][Full Text] [Related]
5. The health threat of new synthetic opioids as adulterants of classic drugs of abuse.
Rinaldi R; Negro F; Minutillo A
Clin Ter; 2020; 171(2):e107-e109. PubMed ID: 32141480
[TBL] [Abstract][Full Text] [Related]
6. New psychoactive substances: An actual problem or an overestimated phenomenon?
Vaiano F; Pascali JP; Bertol E
Forensic Sci Int; 2019 Nov; 304():109941. PubMed ID: 31574421
[TBL] [Abstract][Full Text] [Related]
7. Adulterants in drugs of abuse: a recent focus of a changing phenomenon.
Di Trana A; Montanari E
Clin Ter; 2022 Feb; 173(1):54-55. PubMed ID: 35147648
[TBL] [Abstract][Full Text] [Related]
8. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review.
Orsolini L; Chiappini S; Corkery JM; Guirguis A; Papanti D; Schifano F
Expert Rev Neurother; 2019 Dec; 19(12):1253-1264. PubMed ID: 31503507
[No Abstract] [Full Text] [Related]
9. New psychoactive substances and low-income countries: a burgeoning (and neglected) crisis.
Del Rio A
Clin Ter; 2022 May; 173(3):224-225. PubMed ID: 35612335
[TBL] [Abstract][Full Text] [Related]
10. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
Giné CV; Espinosa IF; Vilamala MV
Drug Test Anal; 2014; 6(7-8):819-24. PubMed ID: 24470121
[TBL] [Abstract][Full Text] [Related]
11. New psychoactive substances in Australia: patterns and characteristics of use, adverse effects, and interventions to reduce harm.
Sutherland R; Allsop S; Peacock A
Curr Opin Psychiatry; 2020 Jul; 33(4):343-351. PubMed ID: 32250983
[TBL] [Abstract][Full Text] [Related]
12. New Psychoactive Substances consumption and their monito- ring during Covid-19 pandemic.
Di Trana A; La Maida N
Clin Ter; 2021 Jul; 172(4):271-272. PubMed ID: 34247209
[TBL] [Abstract][Full Text] [Related]
13. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
[TBL] [Abstract][Full Text] [Related]
14. Is the issue of Chemsex changing?
Pirani F; Lo Faro AF; Tini A
Clin Ter; 2019; 170(5):e337-e338. PubMed ID: 31612189
[TBL] [Abstract][Full Text] [Related]
15. Drug checking to detect fentanyl and new psychoactive substances.
Palamar JJ; Salomone A; Barratt MJ
Curr Opin Psychiatry; 2020 Jul; 33(4):301-305. PubMed ID: 32187173
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
Gray R; Bressington D; Hughes E; Ivanecka A
J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
[TBL] [Abstract][Full Text] [Related]
17. The Texture of Psychoactive Illicit Drugs in Iran: Adulteration with Lead and other Active Pharmaceutical Ingredients.
Akhgari M; Moradi F; Ziarati P
J Psychoactive Drugs; 2018; 50(5):451-459. PubMed ID: 30130472
[TBL] [Abstract][Full Text] [Related]
18. Sudden cardiac death associated to substances of abuse and psychotropic drugs consumed by young people: A population study based on forensic autopsies.
Morentin B; Callado LF
Drug Alcohol Depend; 2019 Aug; 201():23-28. PubMed ID: 31174141
[TBL] [Abstract][Full Text] [Related]
19. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin.
Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
Postgrad Med; 2018 Jan; 130(1):1-8. PubMed ID: 29190175
[TBL] [Abstract][Full Text] [Related]
20. The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online population.
Kimergård A; Foley M; Davey Z; Wadsworth E; Drummond C; Deluca P
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
